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Abstract
Introduction: While the use of cardiac ECMO is increasing in adult patients, the field lacks
understanding of associated risk factors. Even though standard ICU risk scores such as SAPS II,
SOFA and APACHE II, or disease specific scores such as MELD, RIFLE, PRESERVE and
ECMOnet exist, they may not apply to adult cardiac ECMO patients as their risk factors differ
from variables used in these scores.
Methods: Between 2010 and 2014, 73 ECMO were performed for cardiac support at our
institution. Patient demographics and survival were retrospectively analyzed. A new easily
calculated score for predicting ECMO mortality was created using identified risk factors from
univariate and multivariate analyses, and model discrimination was compared to other scoring
systems.
Results: Cardiac ECMO was performed on 73 patients (47 males and 26 females) with a mean
age of 48 ± 14 years. 64% of patients (47/73) survived ECMO support. Pre-ECMO SAPS II,
SOFA, APACHE II, MELD, RIFLE, ECMOnet, and PRESERVE scores were not correlated with
survival. Univariate analysis of pre-ECMO risk factors demonstrated that elevated lactate, renal
dysfunction, and post-cardiotomy cardiogenic shock were risk factors for death. Applying this
data into a new Simplified Cardiac ECMO Score (minimal risk = 0, maximal = 5) predicted
patient survival. Survivors had a lower risk score (1.8 ± 1.2) vs. the non-survivors (3.0 ± 0.99),
p<0.0001.
Conclusions: Common ICU or disease specific risk scores calculated for cardiac ECMO patients
did not correlate with ECMO survival, while a new Simplified Cardiac ECMO Score provides
survival predictability.
Word count of abstract: 249/max 250
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Introduction
For patients with reversible cardiac or respiratory injuries who would otherwise face grim
outlooks and high mortality rate, extracorporeal membrane oxygenation (ECMO) continues to
provide hope for successful recovery. The literature reports that hospital survival rates after
being supported by ECMO range widely from 20% to 65%. 1, 2, 3, 4 Since the indications for
ECMO used to support a patient with cardiac or respiratory failure can differ greatly, it is
important to consider these two populations as different when doing specific analyses.
Patients on ECMO for cardiac failure are supported by veno-arterial (VA) ECMO.
ECMO provides reasonable recovery for patients suffering from cardiac failure as ECMO
survival rates range from 50% to 69% 5, 6, 7, 8 and hospital discharge rates range from 25% to 45%.
7, 5, 9, 10

With the use of ECMO for patient salvage from refractory cardiogenic shock in adult

populations increasing exponentially, a comprehensive analysis of risk factors associated with the
treatment, with the aim of creating a simple risk model, has yet to be completed.
While the literature sets forth an impressive breadth of potential risk factors associated
with cardiac ECMO mortality, there is no clear risk score that can predict the probability of
survival for a patient requiring cardiac ECMO. 5-7,

11, 12

Even though several intensive care unit

(ICU) risk models exist that predict mortality among all ICU patients, patients being supported on
cardiac ECMO may have different risk and treatment profiles compared to other ICU populations.
These common risk scores such as Simplified Acute Physiology Score II (SAPS II), 13 Sequential
Organ Failure Assessment (SOFA), 14 and Acute Physiology And Chronic Health Evaluation II
(APACHE II) 15 may not apply for cardiac ECMO patients.
The present study assesses the survival rate of cardiac ECMO patients at our institution
and attempts to distil a concise and generalizable set of risk factors that apply to this sub-group of
cardiogenic shock patients. Also, this study seeks to determine if the common ICU or disease
specific risk models (SAPS II, SOFA, and APACHE II) apply to cardiac ECMO patients. While
a number of these risk models have been tested in mixed ECMO patient populations previously,
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16, 17, 18

many have yet to be assessed in a patient population specific to cardiac ECMO. Finally,

using the risk factors generated, this study attempts to create and verify a new Simple Cardiac
ECMO Score, which can be used preoperatively to predict ECMO mortality for cardiac ECMO
patients.
Methods
Between August 2010, and June 2014, 107 adult ECMO procedures were performed at
our institution. Among those, 73 ECMO procedures were primarily done for cardiac support.
The standard procedure for cardiac ECMO patients was VA ECMO. The VA ECMO procedure
involved placing a peripheral ECMO cannula though the femoral artery and vein, along with
distal limb perfusion cannula, 19 unless the patient had open chest and peripheral access was not
feasible at the time of VA ECMO placement. No patient was placed on VV ECMO for cardiac
support in our institution. Patient data was entered in a structured IRB approved database. The
latest laboratory value prior to ECMO insertion was entered into the database. The data was
retrospectively analyzed for information regarding patient demographics, preoperative (preECMO) and perioperative (peri-ECMO) conditions, survival, and organ recovery data. The endpoint of this study was ECMO survival vs. ECMO mortality. ICU scores such as SOFA,
APACHE II, and SAPS II, and an organ specific score (Model for End-stage Liver Disease
[MELD], and Kidney Risk, Injury, Failure, Loss of function, ESRD [RIFLE]) were calculated.
Other scores specifically related to ECMO including the ECMOnet 20 and Predicting Death for
Severe ARDS on VV ECMO (PRESERVE) 21 scores were calculated as well.
The results were expressed as number with percentage, or mean ± standard deviation.
Univariate analyses were performed using chi-square or Fisher’s exact tests for categorical
variables, and Student’s t-tests for continuous variables as appropriate to identify the risk factors
of death during ECMO. Multivariate analyses were performed on the variables found to have a p
<0.1 according to univariate analyses to identify independent risk factors for ECMO mortality. A
new model to predict ECMO mortality (Simplified Cardiac ECMO Score) was created using the
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dominant risk factors, as isolated by univariate and multivariate analyses, and reflecting the
logistic regression relationships between selected predictor indicator variables and ECMO
mortality outcome indicators. Receiver operating characteristic curve (ROC) and area under the
curve (AUC) analyses were performed using SAS Software (version 9.4, SAS Institute, Cary,
NC). The model discrimination was examined by comparing the AUC of the Simplified Cardiac
ECMO Score to the AUCs of other conventional ICU and organ specific scores. P-values < 0.05
were considered to be significant.
Results
The 73 patients who received cardiac ECMO at our institution consisted of 47 males and
26 females with a mean age of 48 ± 14 years. The etiologies for ECMO in these patients were
acute myocardial infraction (AMI) (n=19), acute on chronic heart failure (n=14), post-cardiotomy
failure (n=13), malignant arrhythmia (n=11), myocarditis (n=5), Takotsubo cardiomyopathy
(n=2), accidental hypothermia (n=2), acute rejection (n=2), pulmonary embolism (n=2),
constrictive pericarditis (n=1), drug overdose cardiac arrest (n=1), and septic shock (n=1). The
average duration of ECMO support in these patients was 9.2 ± 6.1 days. Among the 73 patients,
47 patients (64%) survived ECMO. Causes of death in patients who died on ECMO included
anoxic brain injury (n=8), stroke (n=8), irreversible cardiac dysfunction (n=3), sepsis (n=3),
irreversible lung disease (n=2), abdominal compartment syndrome with hepato-renal syndrome
(n=1), and failure to control bleeding (n=1). There were no ECMO device related deaths.
Among the 47 ECMO survivors, 39 had improved or unchanged kidney function (83%), 44 had
improved or unchanged liver function (94%), 46 had improved or unchanged lactate trend (98%),
and 43 had improved or unchanged pulmonary edema represented by Murray score (91%) (Table
1).
Among the ECMO survivors, 27/47 patients (57%) were discharged from the hospital.
Causes of death post-ECMO but prior to discharge included sepsis (n=5), neurologic injury (n=4),
AMI due to stent thrombosis (n=2), family’s withdrawal due to failure to thrive (n=2), and one
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case of each of the following: pulseless electric activity after internal defibrillator placement,
persistent loss of cardiac activity despite biventricular assist device placement, acute failure of
left ventricular assist device placement with persistent low flow and malperfusion, non-resectable
cardiac metastasis (adenocarcinoma), and severe coagulopathy and multiple bleeding. Note that 3
patients required two separate cardiac ECMO runs within the same hospital stay. One of these
patients died on the second ECMO run, while two died post ECMO removal.
After univariate analysis of potential pre-ECMO risk factors, high lactate levels (p=0.02),
the presence of post-cardiotomy failure (p=0.03), and a RIFLE score injury or above (p=0.10)
were associated with ECMO mortality (Table 2). We performed separate analyses to attempt to
identify the risk factors for hospital mortality. Only pre-ECMO bicarbonate levels correlated
with hospital mortality (Survivors: 18.3 ± 5.2; Non-survivors: 22.2 ± 6.4; p=0.03).
A new Simplified Cardiac ECMO Score for ECMO mortality was built and applied to
this sample. A potential pre-ECMO risk factor p-value less than or equal to 0.1 as determined by
univariate analyses was considered to be a factor for inclusion into new ECMO score. It was
found that the combination of elevated lactate (>2.0 mmol/dl), renal dysfunction (RIFLE score of
‘injury’ or above), and post-cardiotomy predicted death. According to multivariate logistic
regression analysis, presence of high lactate and post-cardiotomy each had approximately a twofold greater contribution to the odds of dying on ECMO than the presence of renal dysfunction
(Table 3). When combining these parameters into a simply calculated score as shown in Table 3,
the Simplified Cardiac ECMO Scores (minimum = 0, maximum = 5) were significantly different
between ECMO survivors and non-survivors (p<0.001), while no such differences were detected
for among any of the other pre-ECMO ICU or disease-specific risk scores (Table 4). The
mortality rates progressively increased with a higher Simplified Cardiac ECMO Score; mortality
was 0% (deaths/number of patients = 0/10) for a Simple Cardiac ECMO Score of 0, 20% (1/5) for
a Score of 1, 29% (6/21) for a Score of 2, 50% (11/22) for a Score of 3, 71% (5/7) for a Score of
4, and 100% (2/2) for a score of 5 (Figure 1). The Simplified Cardiac ECMO Score and these
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mortality percentages had a linear correlation ([mortality%] = 19.26 x [Simple Cardiac ECMO
Score] – 22.4, R2=0.98).
Following the production of ROC curves an analysis of the AUCs for the previously
mentioned ICU and disease-specific risk scores was completed, along with the Simplified Cardiac
ECMO Score (Figure 2-4). The Simple Cardiac ECMO Score demonstrated significantly better
prediction of ECMO mortality (AUC = 0.77) as compared to SAPS II, SOFA, MELD, RIFLE,
and PRESERVE scores (AUC ≤ 0.60, Table 5). Statistical significance was not reached relative
to APACHE II and ECMOnet scores.
Discussion
The ECMO and hospital survival results from our institution are consistent with those
from other previous studies of cardiac ECMO. 5, 6, 7, 9, 10 However, there remains limited data
from previous studies to suggest which patients make good candidates for cardiac ECMO, and
which patients are futile cases. While previous studies have determined various risk factors for
cardiac ECMO patients, no studies to date have isolated a specific risk score for this patient
population. By utilizing an easily calculated risk score for cardiac ECMO patients, physicians
can evaluate in which patients the use of cardiac ECMO presents elevated risk of mortality.
While the majority of cardiac ECMO patients are supported in the ICU, traditional ICU
risk scores do not apply because they utilize variables that do not apply to most ECMO patients.
For example, in the APACHE II, SOFA and SAPS II scores, PaO2 and FiO2 measures are
irrelevant because most cardiac ECMO patients are intubated and in pulmonary edema. The
inclusion of the Glasgow Coma Scale (GCS) is not warranted because most patients with
cardiogenic shock are sedated. 13-15 In addition, the SAPS II score takes type of admission, and
whether the patient has any chronic diseases into account, both of which are not pertinent data
points for survival considerations of cardiac ECMO patients. 13 In a study that assessed patients
started on ECMO for refractory post-cardiotomy shock, it was found that a EuroSCORE of
greater than 20% was associated with mortality.7 The EuroSCORE was designed to predict the
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mortality of patients who undergo cardiac surgery and it may co-relate to the outcomes of postcardiotomy failure patients; however, it has minimum value to patients without cardiac surgery.
ECMOnet and PRESERVE scores have both been shown to predict mortality in
respiratory ECMO patients. 20, 21 While these patients are on ECMO support, the etiologies for
ECMO in these patients differ greatly from those being supported on cardiac ECMO. As such,
the predictors of death in these patients will vary from those of cardiac ECMO patients.
ECMOnet scores include measures on pre-ECMO length of stay and hypotension, neither of
which are relevant for cardiac ECMO mortality assessments. 20 Cardiac ECMO patients are often
given vasopressors, so their blood pressure readings can be artificially manipulated. Finally, the
PRESERVE score uses many respiratory measures such as PEEP, plateau pressure, and status on
mechanical ventilation—none of which are pertinent for cardiac ECMO patients. 21 Though
respiratory function may be of utmost relevance to respiratory ECMO mortality, it bears little
influence on cardiac ECMO mortality because of the differing etiologies for and courses of
treatment. While a number of studies have assessed the ability of previously-verified risk scores
to predict mortality in all ECMO patients (both cardiac and respiratory), because the etiologies
for ECMO in these two patient groups differ so widely, it is our impression that these two
populations must be considered separately. 1, 17, 18
An organ system-specific score, the MELD score, also showed a poor correlation with
cardiac ECMO mortality. This is likely because the MELD score was designed specifically to
predict mortality in patients with primary liver failure, but the liver dysfunction in cardiac ECMO
patients are more likely secondary to cardiogenic shock. 22 The MELD score was primarily
designed to evaluate patients for potential liver transplants, and a prerequisite for its usage is
normal cardiac function. 22 Cardiac ECMO patients have severely compromised cardiac function,
and the MELD score cannot be applied to this patient population.
One of the factors incorporated into the Simple Cardiac ECMO Score was a patient’s
RIFLE score, as RIFLE values greater than or equal to ‘injury’ were nearly significant (survivors:
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16 [34%], Non-survivors 14 [54%], p=0.100). This is likely due to the fact that kidney function
is an important factor in ECMO survival, since other essential states such as metabolic acidosis
and high lactate could be related to renal function. However, when comparing the AUC of the
RIFLE score to that of the Simple Cardiac ECMO Score, the latter showed a statistically
significant stronger association with positive prediction. This is because RIFLE does not portray
the entire clinical picture of patients with cardiogenic shock.23 Metabolic acidosis and high lactate
in cardiogenic shock patients reflect the degree of poor perfusion due to cardiac failure, more so
than direct kidney injury. Kidney failure can be supported with temporary continuous veno-veno
hemodialysis.
The issue of pre-ECMO lactate levels correlating with ECMO survival is widely
discussed in the literature. A number of sources claim that lactate levels do influence survival, 7,
10

while others have failed to find a connection. 6 Our patient sample demonstrated that elevated

lactate levels independently predicted mortality in the population. This lactate level may reflect
the degree of malperfusion prior to ECMO. We were unable to identify a series discrete lactate
levels that progressively increased the utility of our model. Rather than investigating various cutoff points for lactate levels, we used a marker of ‘normal’ or ‘abnormal’ levels to keep our score
easy and simple to calculate. Post-cardiotomy cardiogenic shock in our patient sample yielded
significant mortality results, suggesting it greatly impacts cardiac ECMO survival as well. After
performing multivariate analysis, both high lactate and post-cardiotomy had approximately
double the predictive odds of renal dysfunction. Accordingly, we have given elevated lactate and
the diagnosis of being post-cardiotomy double the weight of renal dysfunction in our scoring
system.
The implementation of the Simplified Cardiac ECMO Score yielded an acceptable AUC
value, suggesting beneficial clinical utility. In addition to the above listed shortcomings for the
cardiac ECMO patient population, all the ICU, disease-specific, and other ECMO-specific scores
are very difficult to calculate, and often require software to determine expected mortality. This
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can take valuable time when in an emergent situation, and can also potentially dissuade clinicians
from using the scores at all. Importantly, the Simplified Cardiac ECMO is easy to calculate.
Unlike many other risk scores, physicians do not need an algorithm or calculator to calculate the
Simple Cardiac ECMO Score. Clinicians who are treating the refractory cardiogenic patient can
simply calculate this Simple Cardiac ECMO Score in their head to have a well-informed view of
the patient’s prognosis. The intention of this score is not to exclude patients from cardiac ECMO.
However, in a setting in which demand for ECMO exceeds the resources of a particular hospital,
this score may help physicians allocate hospital resources appropriately. This scoring system
may also help physicians determine the prognosis of patients on cardiac ECMO to assess
potential recovery.
Because our sample size was limited, we were unable to show a statistically significant
increase in AUC relative to two of the other risk scores analyzed. Moreover, we did not have a
sufficient sample to rigorously validate the model. That said, the Simplified Cardiac ECMO
Score did provide a significantly higher predictive capacity, as measured by AUC, relative to five
other risk scores, and it provides an early guide to identify futile cases in this high-risk patient
population. This study assesses risk factors for the cardiac ECMO procedure itself, rather than
hospital discharge. This is because being successfully discharged from the hospital can be altered
by many post-ECMO issues, and may not be directly related to the ECMO procedure. In fact,
separate analyses showed that only pre-ECMO bicarbonate levels predicted hospital mortality and
we failed to create risk model. This study was also limited by its retrospective nature from a
single institution. Future research should use the Simplified Cardiac ECMO Score in larger
samples of cardiac ECMO patients to determine its utility in accurately predicting ECMO
mortality in the population when compared with other ICU risk scores.
Conclusion
Commonly used ICU and disease-specific risk scores do not accurately predict ECMO
mortality for patients supported on ECMO for primary cardiac failure. The Simple Cardiac
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ECMO Score, determined by post-cardiotomy, renal failure, and high lactate, successfully
predicted ECMO mortality. This score may help physicians avoid futile efforts and allocate
resources in an effective and efficient manner.
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Table 1: Organ function before and after ECMO (ECMO Survivors)

Creatinine (mg/dl)

1.5 ± 0.8

Before ECMO
decannulation
1.2 ± 0.5

Alanine aminotransferase (IU/L)

260 ± 629

79 ± 142

Lactate (mmol/L)

5.5 ± 4.5

1.6 ± 1.0

2 ± 1.5

1 ± 0.9

Pre-ECMO

Murray score
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Table 2: Univariate analyses of patient demographics, clinical risk factors, laboratory data before
ECMO.
ECMO
Survivors
N=47

ECMO
Non-Survivors
N=26

49 ± 13
33 (70%)

48 ± 15
14 (54%)

0.780
0.162

90 ± 27

81 ± 21

0.135

29 ± 7.0

29 ± 7.1

0.726

16 (34%)
20 (43%)

5 (19%)
12 (46%)

0.181
0.767

Diabetes
Primary Diagnosis

12 (26%)

9 (35%)

0.412

Acute myocardial infraction
Post-cardiotomy failure
E-CPR
Laboratory data

14 (30%)
5 (11%)
14 (30%)

5 (19%)
8 (31%)
7 (27%)

0.325
0.031
0.800

White blood cell count (B/L)
Hemoglobin (g/dl)
Platelet count (B/L)
PaO2 (mm Hg)

13.5 ± 6.5
11.6 ± 3.1
211 ± 143
149 ± 116

13.9 ± 5.8
11.3 ± 2.7
179 ± 107
126 ± 114

0.772
0.629
0.283
0.434

PaCO2 (mm Hg)
HCO3 (mmol/L)
HCO3 < 20 mmol/L
Creatinine (g/dl)

41 ± 12
20 ± 6.0
20 (43%)
1.5 ± 0.8

44 ± 19
18 ± 6.0
13 (50%)
1.7 ± 0.8

0.454
0.252
0.540
0.254

RIFLE score injury or above

16 (34%)

14 (54%)

0.100

Bilirubin (mg/dl)

1.4 ± 1.4

2.0 ± 2.3

0.256

520 ± 1936

612 ± 1195

0.812

5.5 ± 4.9
31 (66%)

9.4 ± 7.4
24 (92%)

0.020
0.012

p

Pre ECMO demographics
Age
Male gender
Body weight (kg)
2

Body mass index (kg/m )
Clinical risk factors
Smoking history
Coronary artery disease

Aspartate transaminase (IU/L)
Lactate (mmol/L)
Lactate > 2 mmol/L

E-CPR: ECMO assisted cardiopulmonary resuscitation.

15

Table 3: Multivariate logistic regression analyses of ECMO mortality.

Odds
Ratio

Chi square

p

Proposed
weight for New
Simplified
ECMO Score

Post-cardiotomy

1.99

6.33

0.012

2

Lactate above 2

2.39

6.29

0.012

2

RIFLE score injury or above

1.22

3.82

0.050

1
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Table 4: Analyses of ICU, disease specific, and ECMO related scores.

SAPS II
SOFA

ECMO
Survivors
51.7 ± 17.7
13.2 ± 2.5

ECMO
Non-Survivors
54.6 ± 18.3
13.6 ± 2.5

0.626
0.485

APACHE II

28.8 ± 8.02

31.9 ± 7.4

0.136

MELD
PRESERVE

16.3 ± 7.9
5.5 ± 2.7

19.6 ± 9.6
5.4 ± 2.5

0.155
0.959

ECMOnet
Simple Cardiac ECMO Score

4.7 ± 1.8
1.8 ± 1.2

5.6 ± 2.1
3.0 ± 0.99

0.076
<0.001

Pre-ECMO Scores

p

APACHE II: acute physiology and chronic health evaluation II; ECMO: extracorporeal
membrane oxygenation; MELD: model for end-stage liver disease; PRESERVE: predicting death
for severe ARDS on VV ECMO; RIFLE: kidney risk, injury, failure, loss of function, ESRD;
SAPS II: simplified acute physiology score II ; SOFA: sequential organ failure assessment score.
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Table 5: Comparisons of area under the curves (AUCs)

Score

AUC

Simple Cardiac ECMO
SAPS II
SOFA
APACHE II
MELD
RIFLE
PRESERVE
ECMO net

0.77
0.54
0.55
0.60
0.57
0.60
0.49
0.62

p
(Compared to Simple Cardiac ECMO Score)
---0.0026
0.0019
0.2043
0.0183
0.0315
0.0050
0.1002

APACHE II: acute physiology and chronic health evaluation II; MELD: model for end-stage liver
disease; PRESERVE: predicting death for severe ARDS on VV ECMO; RIFLE: kidney risk,
injury, failure, loss of function, ESRD; SAPS II: simplified acute physiology score II; SOFA:
sequential organ failure assessment score.
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Figure 1: Survival Percentages for each Simplified Cardiac ECMO Score. Presence of each of
the following pre-ECMO predictors count as points toward the aggregated score: Lactate >2
mmol/dl (2 points), Renal injury or above including injury, failure, and loss) (1 point), PostCardiotomy (2 points).
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Figure 2: Receiver operating characteristic curves for Simple Cardiac ECMO, APACHE II,
SOFA, and SAPS II. APACHE II: acute physiology and chronic health evaluation II; ECMO:
extracorporeal membrane oxygenation; SAPS II: simplified acute physiology score II ; SOFA:
sequential organ failure assessment score.
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Figure 3: Receiver operating characteristic curves for Simple Cardiac ECMO, PRESERVE, and
ECMOnet. ECMO: extracorporeal membrane oxygenation; PRESERVE: predicting death for
severe ARDS on VV ECMO.
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Figure 4: Receiver operating characteristic curves for Simple Cardiac ECMO, MELD and RIFLE
score. ECMO: extracorporeal membrane oxygenation; MELD: model for end-stage liver disease;
RIFLE: kidney risk, injury, failure, loss of function, ESRD.
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